Hard to justify a $930M market cap with CEO announcing DexCom's fiscal year 2011 product revenue of $67.5 - $72.5 million. This is below analyst predictions which were already lowered 2 months ago to $73.6M. Seems overbought here.
64slice, You may be on to something there, sneak in and short the hell out of DXCM and you might make a killing when the unwashed masses realize they have been duped. Do you have a newsletter or website where I can follow htis insightful analysis?